125 related articles for article (PubMed ID: 8403703)
1. Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma.
Markowitz A; Saleemi K; Freeman LM
Clin Nucl Med; 1993 Aug; 18(8):685-700. PubMed ID: 8403703
[TBL] [Abstract][Full Text] [Related]
2. Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
Abdel-Nabi HH; Doerr RJ
Targeted Diagn Ther; 1992; 6():73-88. PubMed ID: 1576351
[TBL] [Abstract][Full Text] [Related]
3. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
Doerr RJ; Herrera L; Abdel-Nabi H
Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
[TBL] [Abstract][Full Text] [Related]
4. Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.
Collier BD; Abdel-Nabi H; Doerr RJ; Harwood SJ; Olsen J; Kaplan EH; Winzelberg GG; Grossman SJ; Krag DN; Mitchell EP
Radiology; 1992 Oct; 185(1):179-86. PubMed ID: 1523304
[TBL] [Abstract][Full Text] [Related]
5. Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.
Perkins AC; Vincent RM; Wastie ML; Denton GW; Amar S; Hardcastle JD
Nucl Med Commun; 1994 Dec; 15(12):981-90. PubMed ID: 7715898
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
[TBL] [Abstract][Full Text] [Related]
7. [Indium 111-labeled antibodies in the detection of colorectal carcinoma].
Artiko V; Obradović V; Davidović B; Petrović N; Petrović M; Krivokapić Z; Pavlov M; Adanja G; Sobić D; Vlajković M; Pavlović S; Rebić R
Acta Chir Iugosl; 2003; 50(4):43-6. PubMed ID: 15307496
[TBL] [Abstract][Full Text] [Related]
8. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunodetection of colorectal carcinoma.
Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
[TBL] [Abstract][Full Text] [Related]
10. Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Bohdiewicz PJ; Scott GC; Juni JE; Fink-Bennett D; Wilner F; Nagle C; Dworkin HJ
Clin Nucl Med; 1995 Mar; 20(3):230-6. PubMed ID: 7750217
[TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy of colorectal carcinoma utilizing 111In-labeled monoclonal antibody conjugate CYT-103.
Neal CE; Swan TL; Baker MR; Ellis RL; Katterhagen JG
Gastrointest Radiol; 1991; 16(3):251-5. PubMed ID: 1879645
[TBL] [Abstract][Full Text] [Related]
12. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
[TBL] [Abstract][Full Text] [Related]
13. In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma.
Neal CE; Baker MR; Hilgers RD; Fanning J; Burke RC; Snodgrass J; Cull RD
Clin Nucl Med; 1993 Jun; 18(6):472-6. PubMed ID: 8319398
[TBL] [Abstract][Full Text] [Related]
14. Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.
Petersen BM; Bass BL; Bates HR; Chandeysson PL; Harmon JW
Am J Surg; 1993 Jan; 165(1):137-42; discussion 142-3. PubMed ID: 8418688
[TBL] [Abstract][Full Text] [Related]
15. Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
Surwit EA; Childers JM; Krag DN; Katterhagen JG; Gallion HH; Waggoner S; Mann WJ
Gynecol Oncol; 1993 Mar; 48(3):285-92. PubMed ID: 8462896
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
[TBL] [Abstract][Full Text] [Related]
17. Site of mistletoe injection observed on In-111 OncoScint imaging.
Choe W
Clin Nucl Med; 1997 Feb; 22(2):127. PubMed ID: 9031776
[No Abstract] [Full Text] [Related]
18. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up.
Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z
Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193
[TBL] [Abstract][Full Text] [Related]
19. Detection of recurrent colorectal carcinoma with In-111 CYT-103 scintigraphy in a patient with nondiagnostic MRI and CT.
Edlin JP; Kahn D
Clin Nucl Med; 1994 Nov; 19(11):1004-7. PubMed ID: 7842571
[TBL] [Abstract][Full Text] [Related]
20. OncoScint CR103 imaging in the surgical management of patients with colorectal cancer.
Doerr RJ; Abdel-Nabi HH
Targeted Diagn Ther; 1992; 6():89-109. PubMed ID: 1576352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
